
"Malaria Vaccine Rollout in Mali: A Crucial Step Towards Eliminating the Disease"
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Acerca de esta escucha
Mali has been at the forefront of this effort, marking a historic step with the introduction of the anti-malaria vaccine. The official launch of the vaccine took place on April 25, coinciding with World Malaria Day, in the commune of Kalaban-Coro near Bamako. This initiative is driven by the commitment of health workers, local communities, and religious leaders, who are crucial in raising awareness and ensuring the vaccine's success. The R21/Matrix-M vaccine will be deployed in 19 priority health districts across five regions, targeting children aged 5 to 36 months with a five-dose vaccination schedule[1][4].
This vaccine is part of a broader strategy that complements existing prevention tools such as seasonal malaria chemoprevention (SMC) and the use of insecticide-treated mosquito nets. According to WHO recommendations, the best individual protection for children under five combines these measures, highlighting the importance of a multi-faceted approach in combating malaria[1][2].
The rollout of malaria vaccines is not limited to Mali; it is part of a larger initiative across Africa. By early April 2025, 19 countries had introduced the vaccine sub-nationally as part of routine childhood vaccinations, with plans for further scale-up throughout the year. Both the R21 and RTS,S vaccines have been prequalified by the WHO and have shown to be safe and efficacious, reducing malaria cases by more than half during the first year after vaccination. A fourth dose given in the second year of life prolongs this protection, and when used seasonally in highly seasonal transmission areas, these vaccines can reduce malaria cases by 75%[2].
The impact of these vaccines is expected to be substantial, with tens of thousands of young lives potentially saved every year. The introduction and scaling up of these vaccines are seen as critical in enhancing global malaria elimination efforts, especially in the face of challenges such as climate change, drug-resistant strains, and new variants of mosquitoes[2][5].
In summary, the recent rollout of malaria vaccines in countries like Mali represents a significant step forward in the battle against malaria, offering new hope for a safer future for children in regions heavily affected by this disease.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones